Tasso
Dr. Ben Casavant sets Tasso's operational goals, keeping the company on track to achieve each defined milestone.
Ben holds an undergraduate degree in Bioengineering from the University of California, Berkeley, and a PhD in Biomedical Engineering from the University of Wisconsin-Madison. Ben is the author of over 22 publications and 5 patent applications.
Tasso
3 followers
Tasso is an emerging healthcare company that is transforming the traditional blood collection process with a more convenient and virtually painless approach that focuses on the patient. The company’s OnDemand devices allow people to collect blood with the push of a button from the comfort and privacy of their home, and then mail the samples back to a qualified laboratory for analysis. Headquartered in Seattle, Tasso is privately held and funded by grants from the Defense Advanced Research Projects Agency, Defense Threat Reduction Agency, and the National Institutes of Health, by investments from Hambrecht Ducera Growth Ventures, Merck Global Health Innovation Fund, Foresite Capital, Vertical Venture Partners, Techstars, and Cedars Sinai, and by co-development deals with various industry leaders.